Zhejiang Medicine Co Ltd (600216) — Capital Reinvestment Ratio
Latest as of September 2025:
0.12x
Zhejiang Medicine Co Ltd (600216) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥690.77 Million) in capital expenditures (CN¥80.03 Million). See 600216 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥690.77 Million
CNY
Capital Expenditures
CN¥80.03 Million
CNY
Data as of
Sep 2025
Most recent filing
Zhejiang Medicine Co Ltd Capital Reinvestment Ratio (1998–2025)
This chart tracks Zhejiang Medicine Co Ltd's Capital Reinvestment Ratio across 27 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Medicine Co Ltd from 1998 to 2025. For live market cap and broader valuation context, see market value of Zhejiang Medicine Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥1.89 Billion | CN¥446.47 Million | ▼ -58.0% |
| 2024 | 0.56x | CN¥1.22 Billion | CN¥689.14 Million | ▼ -55.2% |
| 2023 | 1.26x | CN¥634.31 Million | CN¥796.87 Million | ▼ -33.0% |
| 2022 | 1.87x | CN¥520.60 Million | CN¥975.99 Million | ▲ +126.8% |
| 2021 | 0.83x | CN¥1.14 Billion | CN¥939.60 Million | ▲ +94.1% |
| 2020 | 0.43x | CN¥1.26 Billion | CN¥535.35 Million | ▼ -66.8% |
| 2019 | 1.28x | CN¥447.25 Million | CN¥573.63 Million | ▲ +69.3% |
| 2018 | 0.76x | CN¥579.91 Million | CN¥439.30 Million | ▼ -33.1% |
| 2017 | 1.13x | CN¥503.47 Million | CN¥569.99 Million | ▼ -0.3% |
| 2016 | 1.14x | CN¥336.14 Million | CN¥381.76 Million | ▼ -83.3% |
| 2015 | 6.80x | CN¥106.54 Million | CN¥724.96 Million | ▲ +277.3% |
| 2014 | 1.80x | CN¥549.90 Million | CN¥991.76 Million | ▼ -0.5% |
| 2013 | 1.81x | CN¥655.09 Million | CN¥1.19 Billion | ▲ +54.8% |
| 2012 | 1.17x | CN¥807.49 Million | CN¥945.50 Million | ▲ +210.2% |
| 2011 | 0.38x | CN¥912.75 Million | CN¥344.58 Million | ▲ +240.6% |
| 2010 | 0.11x | CN¥1.32 Billion | CN¥145.90 Million | ▲ +6.0% |
| 2009 | 0.10x | CN¥1.47 Billion | CN¥153.13 Million | ▼ -3.7% |
| 2008 | 0.11x | CN¥1.20 Billion | CN¥130.27 Million | ▼ -83.9% |
| 2007 | 0.67x | CN¥227.67 Million | CN¥153.37 Million | ▼ -54.3% |
| 2006 | 1.47x | CN¥169.51 Million | CN¥249.99 Million | ▼ -89.2% |
| 2005 | 13.60x | CN¥25.14 Million | CN¥341.93 Million | ▲ +910.5% |
| 2004 | 1.35x | CN¥107.60 Million | CN¥144.80 Million | ▼ -32.2% |
| 2003 | 1.98x | CN¥66.20 Million | CN¥131.37 Million | ▼ -78.5% |
| 2002 | 9.25x | CN¥23.13 Million | CN¥213.81 Million | ▲ +654.2% |
| 2001 | 1.23x | CN¥98.25 Million | CN¥120.44 Million | ▼ -89.5% |
| 2000 | 11.69x | CN¥10.58 Million | CN¥123.69 Million | ▲ +435.0% |
| 1998 | 2.18x | CN¥57.72 Million | CN¥126.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow